Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
- PMID: 26848259
- PMCID: PMC4723024
- DOI: 10.2147/DDDT.S100639
Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
Comment in
-
Author's reply.Drug Des Devel Ther. 2016;10:355-6. Drug Des Devel Ther. 2016. PMID: 27104225 No abstract available.
Comment on
-
Maraviroc: a review of its use in HIV infection and beyond.Drug Des Devel Ther. 2015 Oct 1;9:5447-68. doi: 10.2147/DDDT.S90580. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26491256 Free PMC article. Review.
References
-
- Genebat M, Ruiz-Mateos E, Leon JA, et al. Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients. J Antimicrob Chemother. 2009;64:845–849. - PubMed
-
- Hernández-Novoa B, Madrid-Elena N, Dronda F, et al. Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients. J Antimicrob Chemother. 2014;69:1916–1919. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
